"These emissions drive global warming, exacerbating the very respiratory conditions inhalers are meant to relieve," researchers wrote.

Nerandomilast is the first FDA-approved treatment for IPF in over a decade, targeting lung function decline. The FDA has approved nerandomilast (Jascayd; Boehringer Ingelheim) for the treatment of ...

RAHWAY, N.J.- Merck has completed its $10 billion buyout of the British biopharmaceutical company Verona. The deal was first announced in July. It brings the chronic obstructive pulmonary disease ...

Patients who progressed on first- or second-line therapy were the population evaluated in the CABINET trial (NCT03375320). Anthony suggests that patients with pancreatic and pulmonary NETs, ...

Maren Denison, third-year student at the University of Iowa, was in sixth grade when she found out her lung function had dropped to 60 percent as half of her lung had collapsed and was scarred shut.

We all know that asthma impacts breathing. What may be less known is that the disease, which restricts our airways due to inflammatory responses, can be caused throughout our lifetime by a variety of ...

Inhaler use is producing millions of metric tonnes of emissions and having a big impact on global warming, a new study has suggested. The findings, published in journal JAMA, found inhaler-related ...

Five years on, long COVID’s clinical picture is sharpening, revealing persistent lung changes, immune dysregulation, and a complex but vital role for rehabilitation.

"They are these tiny little products, and it's hard to imagine that they can be such contributors, but it's an eminently fixable problem," a study co-author said.

DANBURY, Conn. and BURLINGTON, Mass., Oct. 07, 2025 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) successfully completed the previously announced acquisition of scPharmaceuticals Inc.

Additional Transaction Details Under the terms of the acquisition agreement, Merck, through a subsidiary, has acquired all outstanding shares of Verona Pharma for $107 per ADS, each of which ...